iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value
$0.71−0.03 (-3.81%)
Close on Nov 11, 2026Market cap $1.79MP/E –Yield –
iSpecimen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for iSpecimen
iSpecimen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?